Tower Research Capital (TRC)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$479K Sell
5,556
-6,634
-54% -$595K 0.01% 940
2025
Q4
$1.06M Buy
12,190
+6,142
+102% +$466K 0.03% 493
2025
Q3
$346K Buy
6,048
+2,620
+76% +$151K 0.01% 1093
2025
Q2
$202K Sell
3,428
-739
-18% -$47.7K 0.01% 1765
2025
Q1
$305K Sell
4,167
-2,316
-36% -$191K 0.01% 1130
2024
Q4
$536K Buy
6,483
+4,175
+181% +$329K 0.01% 1007
2024
Q3
$165K Sell
2,308
-3,632
-61% -$256K ﹤0.01% 1793
2024
Q2
$407K Buy
5,940
+707
+14% +$42.2K 0.01% 1507
2024
Q1
$281K Sell
5,233
-13,973
-73% -$751K 0.01% 1202
2023
Q4
$1.02M Buy
19,206
+14,666
+323% +$715K 0.01% 840
2023
Q3
$225K Sell
4,540
-168
-4% -$9.39K 0.01% 1357
2023
Q2
$280K Buy
4,708
+3,355
+248% +$191K 0.01% 1338
2023
Q1
$77K Sell
1,353
-308
-19% -$19.8K ﹤0.01% 2105
2022
Q4
$124K Sell
1,661
-2,471
-60% -$168K 0.01% 1661
2022
Q3
$246K Sell
4,132
-1,971
-32% -$119K ﹤0.01% 1715
2022
Q2
$343K Sell
6,103
-5,607
-48% -$369K 0.01% 1381
2022
Q1
$864K Buy
11,710
+6,489
+124% +$451K 0.01% 852
2021
Q4
$377K Buy
5,221
+1,908
+58% +$139K 0.01% 1316
2021
Q3
$254K Sell
3,313
-3,091
-48% -$248K 0.01% 1585
2021
Q2
$497K Sell
6,404
-1,496
-19% -$106K 0.01% 1193
2021
Q1
$487K Sell
7,900
-11,321
-59% -$717K 0.01% 1263
2020
Q4
$1.25M Sell
19,221
-30,131
-61% -$1.73M 0.04% 396
2020
Q3
$2.44M Buy
49,352
+17,777
+56% +$917K 0.03% 280
2020
Q2
$1.51M Buy
31,575
+31,533
+75,079% +$1.52M 0.06% 325
2020
Q1
$2K Sell
42
-5,081
-99% -$251K ﹤0.01% 2584
2019
Q4
$302K Buy
5,123
+4,187
+447% +$227K 0.03% 442
2019
Q3
$48K Sell
936
-6,798
-88% -$324K ﹤0.01% 1825
2019
Q2
$328K Buy
+7,734
New +$336K 0.02% 648
2019
Q1
Sell
-550
Closed -$23K 3971
2018
Q4
$23K Sell
550
-4,849
-90% -$242K ﹤0.01% 1821
2018
Q3
$306K Buy
5,399
+3,119
+137% +$164K 0.02% 745
2018
Q2
$115K Sell
2,280
-9,848
-81% -$514K 0.01% 1355
2018
Q1
$604K Buy
12,128
+11,725
+2,909% +$551K 0.05% 384
2017
Q4
$16K Sell
403
-6,322
-94% -$221K ﹤0.01% 2225
2017
Q3
$200K Buy
6,725
+6,610
+5,748% +$202K 0.02% 766
2017
Q2
$4K Sell
115
-537
-82% -$16.9K ﹤0.01% 2092
2017
Q1
$19K Sell
652
-3,252
-83% -$88.8K ﹤0.01% 1328
2016
Q4
$97K Buy
+3,904
New +$88.7K 0.01% 986
2016
Q3
Sell
-6,925
Closed -$165K 3930
2016
Q2
$165K Buy
6,925
+5,461
+373% +$131K 0.02% 782
2016
Q1
$35K Buy
1,464
+964
+193% +$23.6K 0.01% 969
2015
Q4
$14K Sell
500
-5,512
-92% -$138K ﹤0.01% 1690
2015
Q3
$125K Buy
6,012
+5,560
+1,230% +$141K 0.01% 458
2015
Q2
$12K Buy
+452
New +$11.4K ﹤0.01% 2528
2015
Q1
Sell
-570
Closed -$14K 4606
2014
Q4
$14K Buy
570
+346
+154% +$7.66K ﹤0.01% 1843
2014
Q3
$4K Sell
224
-6,043
-96% -$124K ﹤0.01% 3423
2014
Q2
$150K Buy
6,267
+5,205
+490% +$126K 0.02% 710
2014
Q1
$28K Buy
+1,062
New +$25.2K ﹤0.01% 1568
2013
Q4
Sell
-1,942
Closed -$34K 4639
2013
Q3
$34K Buy
1,942
+1,464
+306% +$25.3K ﹤0.01% 2245
2013
Q2
$8K Buy
+478
New +$7.38K ﹤0.01% 2561

Other funds holding GMED